Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-23-049357

See Remarks sold 7,672 shares at $10.41 ($79,866)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brumm Joshua T See Remarks 2023-09-12 Sale −7,672 $10.41 $79,866 245,711 D
Open-market sales · 7,672 sh · avg $10.41 · $79,866
Loading xslF345X05/doc4.xml…